Horizon Technology Finance Corporation (HRZN)
NASDAQ: HRZN · Real-Time Price · USD
7.34
-0.02 (-0.27%)
Jun 23, 2025, 4:00 PM - Market closed
Company Description
Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments.
It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, cleantech and sustainability industries.
It seeks to invest in companies in the United States.
Horizon Technology Finance Corporation
Country | United States |
Founded | 2008 |
IPO Date | Oct 29, 2010 |
Industry | Asset Management |
Sector | Financials |
CEO | Michael Balkin |
Contact Details
Address: 312 Farmington Avenue Farmington, Connecticut 06032-2586 United States | |
Phone | 860 676 8654 |
Stock Details
Ticker Symbol | HRZN |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001487428 |
CUSIP Number | 44045A102 |
ISIN Number | US44045A1025 |
Employer ID | 27-2114934 |
Key Executives
Name | Position |
---|---|
Michael P. Balkin | Chief Executive Officer and Director |
Gerald A. Michaud | Executive Officer |
Daniel Raffaele Trolio CPA | Executive Vice President, Chief Financial Officer and Treasurer |
Paul Seitz | Chief Investment Officer |
Lynn D. Dombrowski | Vice President and Chief Accounting Officer |
Megan N. Bacon | Director of Investor Relations and Marketing |
John C. Bombara J.D. | Executive Vice President, General Counsel, Secretary and Chief Compliance Officer |
Kevin T. Walsh | Senior MD and Head of Portfolio Management |
Todd A. McDonald | Head of Technology Lending and Senior Managing Director |
Mishone B. Donelson | Head of Life Science Lending, Senior Vice President and Senior Managing Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jun 9, 2025 | 8-K | Current Report |
Jun 5, 2025 | 8-K | Current Report |
May 27, 2025 | 8-K | Current Report |
May 15, 2025 | DEFR14A | Filing |
May 15, 2025 | 8-K | Current Report |
May 14, 2025 | 40-APP | Filing |
Apr 29, 2025 | 10-Q | Quarterly Report |
Apr 29, 2025 | 8-K | Current Report |
Apr 29, 2025 | 8-K | Current Report |
Apr 28, 2025 | 8-K | Current Report |